The first affiliated hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
NCT Number: NCT07096947
The goal of this dual-center study is to identify the most valuable predictive factors (MVPs) for non-curable mixed-type early gastric cancer (NC-MTEGC) and develop a nomogram scoring model to assist surgeons in formulating precise postoperative combined radiochemotherapy strategies in patients with mixed-type early gastric cancer (MTEGC) who have undergone radical surgical resection. The main question it aims to answer is:
What are the most valuable predictive factors for NC-MTEGC, and can a nomogram scoring model developed based on these factors effectively assist in formulating precise postoperative combined radiochemotherapy strategies?
Patients with MTEGC who have undergone radical surgical resection (including 160 in the training group, 151 in the internal validation set from the First Affiliated Hospital of Nanchang University, and 110 in the external test cohort from the Second Affiliated Hospital of Nanchang University) will be included in the study. The Least Absolute Shrinkage and Selection Operator (LASSO) algorithm will be used to assess key predictive indicators, a nomogram prediction model will be developed based on logistic regression, and an NC-MTEGC risk score model will be constructed. Meanwhile, the model's discriminatory ability, calibration, and clinical utility will be comprehensively validated across the three cohorts, with follow-up for relevant conditions.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Nanchang, Jiangxi, 330006, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment to the end of treatment at 5 years
Evaluate the incidence of adverse postoperative prognosis in patients with mixed-type early gastric cancer via the Nomogram model scoring.
Time frame: Periprocedural
Grading criteria refer to clinical guidelines: High risk, Medium risk, Low risk.
Time frame: From enrollment to the end of treatment at 5 years
The status of lymph node metastasis is divided into "no lymph node metastasis (no tumor cell invasion of lymph nodes detected)" and "lymph node metastasis (the presence of tumor cell invasion of lymph nodes)".
Time frame: Periprocedural
Measured and reported in millimeters (mm)
Time frame: Periprocedural
Measured and reported in millimeters (mm)
Time frame: Periprocedural
Staging criteria refer to clinical guidelines
Time frame: Baseline
Binary classification, divided into male and female
Time frame: Periprocedural
Measured and reported as a percentage (%)
Time frame: Periprocedural
Measured and reported as a percentage (%)
Time frame: Periprocedural
The lesion locations are classified as follows: Gastric Body, Gastric Antrum, Gastric Angle, Cardia, Pylorus, and Antrum-Body Junction.
Time frame: Baseline
Measured and reported in nanograms per milliliter (ng/mL)
The First Affiliated Hospital of Nanchang University
Other
A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer: a Retrospective Cohort Study
Acronym: MTEGC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.